Genetic Medicines Biotech Dyne Pulls In $345M for Clinical Tests of Muscle Drugs
Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of ...
Samstag, Januar 18, 2025
Schlagwort: san francisco
Manufacturing Issues Block Astellas From a First-in-Class Cancer Drug Approval
Astellas Pharma’s path to winning the first drug approval for a particular promising gastrointestinal cancer target has hit a detour. ...
Menopause Startup Launches AI-Powered Hot Flash Care Product
Loewen Cavill, co-founder and CEO of Amira, never expected to work in the menopause space. But then her aunt was ...
Reading the Tea Leaves for Cannabis Regulation
The legal status of marijuana in the United States is comparable to the Korean War: The conflict ceased long ago, ...
Boston Scientific Continues Buying Spree with $3.7B Axonics Acquisition
Medical device giant Boston Scientific announced a $3.7 billion deal on Monday to augment its urology portfolio. The company is ...
Pandemic Preparedness for CDMOs: Will It Be Different Next Time?
When the Covid-19 pandemic hit, contract development and manufacturing organizations (CDMOs) became indispensable partners to the biopharmaceutical companies that developed ...
Lawmakers Must Protect California’s Kids and Fund Continuous Coverage Now
Imagine being a parent to a 20-month-old and learning through a developmental screening that your toddler might have autism spectrum ...
Goldman Sachs Closes $650M Fund to Invest in ‘Golden Era’ of Biotech Innovation
Goldman Sachs Asset Management has expanded to biotech investments in recent years. The investment firm is now preparing to ramp ...
Alleviating Patient Burden in Clinical Trials: Modeling a Consumer-Grade Experience
Clinical trial attrition can be detrimental to clinical outcomes, patient well-being and the financial health of research programs. Clinical trial ...